Nuance Communications, provider of conversational AI and ambient intelligence solutions, acquired Saykara, an AI-powered, voice-activated virtual scribe for physicians. Founded in 2015 by Harjinder Sandhu,

Nuance Communications, provider of conversational AI and ambient intelligence solutions, acquired Saykara, an AI-powered, voice-activated virtual scribe for physicians. Founded in 2015 by Harjinder Sandhu,
NeuroFlow, a behavioral health monitoring app powered by artificial intelligence, announced the initial closing of a $20 million Series B financing round led by Magellan
Volta Medical, a developer of intelligence (AI) algorithms that help electrophysiologists improve cardiac arrythmias treatment, raised $28 million in financing. Gilde Healthcare led the round
Healthcare Data Analytics companies received $1.3 billion in venture capital in the first nine months (9M) of 2020, according to Mercom Digital Health Funding and
WithMe Health, an AI-powered personalized medication guidance and navigation app, raised $20 million in a Series B funding round led by OMERS Ventures. Existing investor
Subtle Medical, a provider of AI-powered solutions for vendor-agnostic medical imaging enhancement, raised $12.2 million in a Series A funding round, led by 3E Bioventures
Gleamer, a developer of an AI-powered medical imaging software platform that helps radiologists diagnose their patients, secured €7.5 million (~$8.7 million) in Series A funding.
RapidAI, an AI-powered cerebrovascular imaging platform, raised $25 million in a Series B round led by Lennertz. The additional funds will be used to accelerate
Skin Analytics, a U.K.-based startup that develops AI algorithms for skin cancer detection, raised £4 million (~$5.2 million) in Series A funding, according to TechCrunch.
GEN inCode, a developer of AI products and algorithms to assess cardiovascular disease, raised £3 million (~$4 million) in institutional funding to scale its products